ROCHLIN KATE (Chief Operating Officer) received a stock award from IN8BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/8/2024ACC: 0001415889-24-024871
Officer· Chief Operating Officer
Since Dec 2021
+50.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
62.93K acquired · 12.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.32K
Price / share
—
Trade value
—
% of position
144.2%
10/4/2024
17.56K→42.87K
Total
Net shares
+25.32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2024 | A · Award | +25.32K | — | — | 144.2% | 17.56K | 42.87K |
| Total | +25.32K | $0.00 | ||||||
Derivative Transactions3
Series A Warrants (right to buy)
Direct
Converts to
Common Stock
12.29K shares
Shares
−12.29K
Strike price
1.25
Held after
0.00
Exercisable
—
10/4/2024
Series A Warrants (right to buy)
Direct
Converts to
Common Stock
12.29K shares
Shares
+12.29K
Strike price
0.45
Held after
12.29K
Exercisable
—
10/4/2024
Series C Warrants (right to buy)
Direct
Converts to
Common Stock
25.32K shares
Shares
+25.32K
Strike price
0.27
Held after
25.32K
Exercisable
—
10/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrants (right to buy) Direct | Common Stock12.29K shares | 10/4/2024 | D · Disposition | −12.29K | 1.25 | — | 0.00 |
| Series A Warrants (right to buy) Direct | Common Stock12.29K shares | 10/4/2024 | A · Award | +12.29K | 0.45 | — | 12.29K |
| Series C Warrants (right to buy) Direct | Common Stock25.32K shares | 10/4/2024 | A · Award | +25.32K | 0.27 | — | 25.32K |